These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2434692)

  • 1. [Clinical studies on the microheterogeneity of serum alpha-fetoprotein].
    Ishiguro T; Sugitachi I; Fukui M; Sakaguchi H; Itani S
    Rinsho Byori; 1986 Nov; 34(11):1241-6. PubMed ID: 2434692
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-fetoprotein variants and their clinical significance.
    Xu KL; Yu EX; Lu LN; Zhou J
    Chin Med J (Engl); 1984 Jul; 97(7):538-41. PubMed ID: 6084582
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha1-fetoprotein in liver disease in Sarawak.
    Kothare SN
    Singapore Med J; 1978 Dec; 19(4):220-4. PubMed ID: 87015
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-fetoprotein in patients with primary liver cancer and other liver diseases.
    Zuberi SJ; Lodi TZ; Nazli A
    J Pak Med Assoc; 1977 Jun; 27(6):348-50. PubMed ID: 74425
    [No Abstract]   [Full Text] [Related]  

  • 5. [The early detection of hepatocellular cancer by using alpha-feto-protein microheterogeneity].
    Tu ZX; Wu MC; Cui ZF
    Zhonghua Nei Ke Za Zhi; 1986 May; 25(5):272-5, 317-8. PubMed ID: 2427283
    [No Abstract]   [Full Text] [Related]  

  • 6. [What can be the cause of elevated alpha-fetoprotein after hydrocele surgery?].
    Reiner B
    Dtsch Med Wochenschr; 2002 Mar; 127(9):465. PubMed ID: 11870565
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alkaline phosphatase isoenzymes and alpha-1-fetoprotein in hepatic neoplasms].
    Di Blasi S; Cuffaro M; Rizzo S; Belvedere M; Genova G
    Minerva Med; 1980 Apr; 71(14):1041-6. PubMed ID: 6154909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum alpha-fetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin-E.
    Ishiguro T; Sakaguchi H; Fukui M; Sugitachi I
    Jpn J Surg; 1986 Jan; 16(1):16-21. PubMed ID: 2421034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic significance of alpha-fetoproteins in hepatic pathology].
    Mebazaa A; Ben Naceur M; Rachdi MT; Garoui H; Gargouri M
    Tunis Med; 1985 Mar; 63(3):237-40. PubMed ID: 2411038
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of serum hepatocyte growth factor levels in liver diseases.
    Hioki O; Watanabe A; Minemura M; Tsuchida T
    J Med; 1993; 24(1):35-46. PubMed ID: 7684768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1-fetoprotein.
    Alpert E
    Clin Gastroenterol; 1976 Sep; 5(3):639-44. PubMed ID: 66111
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
    Ishiguro T; Takahashi Y
    Dis Markers; 1989; 7(4):239-45. PubMed ID: 2479498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum alpha fetoproteins (AFP) and immunologic reactivity in chronic liver diseases].
    Nicolaescu T; Bittman E; Bordeianu A; Boroş I; Gheorghe N; Stoiculescu P; Udrescu E; Pecec M; Stihi G; Voiculeţ N; Lenkei R
    Physiologie; 1979; 16(2):139-47. PubMed ID: 92795
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alpha fetoprotein in non-neoplastic liver diseases].
    Piantino P; Pecchio F; Gallo V; Giudice L; Bonardi O
    Minerva Med; 1981 May; 72(18):1125-9. PubMed ID: 6164959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
    Harada T; Shigeta K; Noda K; Fukumoto Y; Nishimura H; Mizuta M; Takemoto T
    Hepatogastroenterology; 1980 Jun; 27(3):169-75. PubMed ID: 6161869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers in focal and diffuse liver diseases].
    Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
    Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha-fetoprotein variants and their significance in the differential diagnosis of primary liver cancer].
    Lu LN
    Zhonghua Yi Xue Za Zhi; 1984 Nov; 64(11):681-3. PubMed ID: 6085280
    [No Abstract]   [Full Text] [Related]  

  • 19. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heterogeneity of alpha-fetoprotein with concanavalin A-binding properties in the serum and ascites of liver neoplasms and liver cirrhosis].
    Fujise K; Nagamori S; Hasumura S; Homma S; Sujino H; Kameda H
    Nihon Shokakibyo Gakkai Zasshi; 1983 Nov; 80(11):2363-8. PubMed ID: 6200631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.